改良无渗透性冷冻保护剂玻璃化法用于隐匿精子症患者≤3条精子的冷冻及7年随访
本研究回顾性评估改良无渗透性冷冻保护剂玻璃化法冷冻隐匿精子症患者≤3条射出精子的效率,并随访2011-2018年经ICSI出生的14名儿童。结果显示精子回收率97.8%、存活率87.1%,临床妊娠率25.0%、活产率21.7%,与新鲜射出精子组及睾丸精子冷冻组无显著差异(除存活率和受精率外);14名儿童体格与认知发育与自然妊娠儿童相当。
要点
- 改良玻璃化法可有效冷冻隐匿精子症患者≤3条射出精子,回收率97.8%、存活率87.1%。
- 冷冻射出精子组临床妊娠率25.0%、活产率21.7%,与新鲜射出精子组无显著差异。
- 14名ICSI子代7年随访体格与认知发育与自然妊娠儿童相当。
核心结论
- 改良无渗透性冷冻保护剂玻璃化法可成功冷冻隐匿精子症患者≤3条射出精子,回收率>95%、存活率近90%。
- 经ICSI出生的子代体格与认知发育与自然妊娠儿童相当。
研究设计与样本
- 回顾性研究于St. Mother Clinic开展,评估≤3条精子冷冻效率。
- 纳入28例隐匿精子症男性(射出精子≤3条,选择冷冻精子而非Micro-TESE)。
- 对照为31例使用新鲜射出精子的隐匿精子症患者和20例非梗阻性无精子症患者(TESE获得<10条精子并玻璃化)。
- 对14名经ICSI使用冷冻射出精子出生的儿童进行7年随访(2011-2018年),使用母子健康手册和KIDS量表评估发育。
主要发现
- 冷冻射出精子回收率97.8%(510/521)、存活率87.1%(444/510);冷冻睾丸精子回收率92.7%(152/164)、存活率60.5%(92/152)。
- 三组临床妊娠率、流产率、活产率分别为:冷冻射出精子组15(25.0)%、2(13.3)%、13(21.7)%;新鲜射出精子组26(24.3)%、5(19.2)%、20(18.7)%;冷冻睾丸精子组3(16.7)%、0(0.0)%、3(16.7)%。
- 除精子存活率和卵母细胞受精率外(冷冻睾丸精子组低于冷冻射出精子组),组间无统计学显著差异。
- 14名ICSI子代7年随访体格与认知发育与自然妊娠儿童相当。
关键数值与推荐
- 冷冻射出精子回收率97.8%(510/521),存活率87.1%(444/510)。
- 冷冻睾丸精子回收率92.7%(152/164),存活率60.5%(92/152)。
- 冷冻射出精子组临床妊娠率25.0%(15例)、流产率13.3%(2例)、活产率21.7%(13例)。
- 新鲜射出精子组临床妊娠率24.3%(26例)、流产率19.2%(5例)、活产率18.7%(20例)。
- 冷冻睾丸精子组临床妊娠率16.7%(3例)、流产率0.0%(0例)、活产率16.7%(3例)。
临床怎么用
- 对隐匿精子症患者射出精子≤3条时,可考虑改良玻璃化冷冻以避免或减少Micro-TESE。
- 该方法适用于极少量睾丸精子(<10条)的冷冻保存。
- 冷冻射出精子的ICSI结局与新鲜射出精子相当,子代发育未见异常。
局限性
- 该方法成功应用的精子数量上限约10条,超过10条时精子在吸管内部碰撞改变方向进入矿物油而无法排出。
- 未发现DNA碎片证据,但需更大样本量和更长随访时间进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What technique can be used to successfully cryopreserve three or fewer ejaculated spermatozoa from cryptozoospermic men and is the physical and cognitive development of children born after this technique normal? SUMMARY ANSWER: The modified cryopreservation method for three or fewer human spermatozoa from cryptozoospermic men showed a recovery rate above 95% and a survival rate just under 90%, and the physical and cognitive abilities of the children born after ICSI were comparable to those born after natural conception. WHAT IS KNOWN ALREADY: Clinical outcomes of ICSI using cryptozoospermic men's ejaculated spermatozoa are considered to be inferior to that using testicular spermatozoa from microsurgical testicular sperm extraction (Micro-TESE), possibly because the DNA fragmentation rate is higher in ejaculated spermatozoa than in testicular spermatozoa from Micro-TESE. STUDY DESIGN, SIZE, DURATION: Evaluation of the efficiency of cryopreservation of three or fewer spermatozoa was conducted retrospectively at St. Mother Clinic. The physical and cognitive development of children born after this method was studied between 2011 and 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study included 28 cryptozoospermic men who had three or fewer morphologically normal and motile spermatozoa in their ejaculate after centrifugation and who preferred using cryopreserved spermatozoa to Micro-TESE. Control subjects were 31 cryptozoospermic patients using fresh spermatozoa from their ejaculates and 20 non-obstructive azoospermic patients with fewer than 10 spermatozoa obtained by TESE and vitrified. Clinical outcomes among three groups, vitrified spermatozoa from the ejaculate, fresh spermatozoa from the ejaculate and vitrified spermatozoa from the testis, were statistically analysed. For the 7-year follow up study of the 14 children born after ICSI using the ejaculated vitrified spermatozoa, the Japanese government-issued Boshi Kenko Techo (Mother-Child Handbook) and Kinder Infant Development Scale (KIDS scale) were used to determine whether their physical and cognitive development was comparable to that of naturally conceived children. MAIN RESULTS AND THE ROLE OF CHANCE: Recovery and survival rates were 97.8% (510/521) and 87.1% (444/510) for vitrified spermatozoa from the ejaculate and 92.7% (152/164) and 60.5% (92/152) for vitrified spermatozoa from the testis. Clinical pregnancies (%), miscarriages (%) and live birth rates (%), respectively, among the three groups were as follows: vitrified spermatozoa from the ejaculate: 15(25.0), 2(13.3), 13(21.7); fresh spermatozoa from the ejaculate: 26(24.3), 5(19.2), 20(18.7); and vitrified spermatozoa from the testis: 3(16.7), 0(0.0), 3(16.7). Among the groups, there were no statistically significant differences except for the sperm survival rate and the oocyte fertilisation rate, which were lower for vitrified spermatozoa from the testis compared with vitrified spermatozoa from the ejaculate. The 7-year follow-up study showed that the physical and cognitive development of 14 children born after ICSI using vitrified ejaculated spermatozoa from the ejaculate was comparable to that of naturally conceived children. LIMITATIONS, REASONS FOR CAUTIONS: The maximum number of spermatozoa to which this method can be applied successfully is about 10. When the number of aspirated spermatozoa is over 10, some of them change direction after colliding with each other inside the aspiration pipette and reach the mineral oil, and once this happens, they cannot be expelled out of the pipette. Even though we did not find evidence of DNA fragmentation, further studies with larger participant numbers and longer time periods are necessary. WIDER IMPLICATIONS OF THE FINDINGS: This technique is very useful for the cryopreservation of very small numbers of testicular spermatozoa (fewer than 10) in order to avoid or reduce Micro-TESE interventions. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received to undertake this study. There are no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Ohno M, Tanaka A, Nagayoshi M, et al. Modified permeable cryoprotectant-free vitrification method for three or fewer ejaculated spermatozoa from cryptozoospermic men and 7-year follow-up study of 14 children born from this method. Hum Reprod. 2020. PMID: 32383453. doi:10.1093/humrep/deaa072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。